Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
1543 results found
2026 ∙ Haute Autorité de Santé
COVID-19 vaccination strategy: revision of the place of the NUVAXOVID vaccine
Recommendation Europe France COVID-19
Download:
2025 ∙ Ndzouboukou, J. L. B. Kamara, A. A. Ullah, N. Lei, Q. Fan, X. L.
A Meta-Analysis on the Immunogenicity of Homologous versus Heterologous Immunization Regimens against SARS-CoV-2 Beta, Delta, and Omicron BA.1 VoCs in Healthy Adults
Adults Older adults COVID-19 Administration Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Banga Ndzouboukou, J. L. Kamara, A. A. Ullah, N. Lei, Q. Fan, X. L.
A meta-analysis on the immunogenicity of prototype, monovalent-adapted and bivalent vaccines against SARS-CoV-2 wildtype, Omicron BA.1 and Omicron BA.4/5 in healthy adults
Adults Older adults COVID-19 Efficacy/effectiveness Administration
Rating:
Critically low
2025 ∙ Hinzpeter, E. L. Kairies-Schwarz, N. Beaudart, C. Douxfils, J. Nayak, D. Hiligsmann, M.
A Systematic Review of Discrete Choice Experiments on Preferences for COVID-19 Vaccinations
All age groups COVID-19 Acceptance
Rating:
Not applicable
2025 ∙ Kalantari, Y. Mirahmadi, S. M. S. Alilou, S. Sadeghi, S. Aryanian, Z. Jafarzadeh, A. Goodarzi, A.
A Systematic Review of Vascular Injuries: A Review of Petechiae, Purpura, and Ecchymosis in Critical Situations Following COVID-19 Vaccination
Adults Older adults COVID-19 Safety
Rating:
Critically low
2025 ∙ Thiyagarajan, G. Nagasubramanian, V. R. Ravichandran, S. L. Baskaran, P. Thangam, D. C. Sankaranarayanan, R. K. Undela, K. Sridevi, B. Pelluri, R. Gurram, P. C. Rajangam, J.
Acceptance and reluctance of COVID-19 vaccination among the general population: a systematic review and meta-analysis of cross-sectional studies
All age groups COVID-19 Acceptance
Rating:
Not applicable
2025 ∙ Min Htike, W. Y. Zhang, M. Wu, Z. Zhou, X. Lyu, S. Kam, Y. W.
Addressing Vaccine Hesitancy in College Students Post COVID-19 Pandemic: A Systematic Review Using COVID-19 as a Case Study
Adolescents Adults Older adults COVID-19 Acceptance
Rating:
Not applicable
2025 ∙ Mink, S. Wilhelm, F. Cadamuro, J. Reimann, P. Fraunberger, P.
Anti-SARS-CoV-2 Antibodies in Long-COVID-Markers of Protection or Elevated Risk? A Systematic Review
All age groups Healthcare workers COVID-19 Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Coyne, B. M. Ito, D. Tariq, A. Lew, S. Q. Kopp, J. Vinales, P. C. Malik, F. Gipson, P. E. Nobakht, E.
Ascertaining the mechanistic etiology of COVID-associated glomerulonephritis: a systematic review
All age groups COVID-19 Safety Administration
Rating:
Critically low
2025 ∙ Sadowski, J. Huk, J. Otulak, S. Zawilo, J. Klaudel, T. Roszak, M. Tenczynski, D. Buldak, R. J.
Association between Guillain-Barre syndrome and SARS-CoV-2 virus infection, including the impact of COVID-19 vaccination in the context of the development and general clinical characteristics of the disease
All age groups COVID-19 Safety Administration
Rating:
Not applicable
Loading...